David Guyer

David R.
Guyer was the founder of Oldtech, Inc. (founded in 2000), where the title held was Chief Executive Officer & Director.
Dr. Guyer was the founder of IVERIC bio, Inc. (founded in 2007), holding the title of Executive Chairman from 2017 to 2021.
Dr. Guyer was the founder of Imagen Biotech, Inc. (founded in 2011), serving as Executive Chairman from 2011 to 2012.
Dr. Guyer is the founder of Eyebiotech Ltd. (founded in 2021), holding the titles of President & Chief Executive Officer.
Current jobs include Chairman at Danube Pharmaceuticals, Inc.; Chairman at Visus Therapeutics, Inc. since 2021; Chairman at Tenpoint Therapeutics Ltd. since 2023; Director at Lux Biosciences, Inc. since 2006; Director at Sound Pharmaceuticals, Inc.; Director at Mimetogen Pharmaceuticals, Inc.; Director at PanOptica, Inc. since 2013; Director at iSTAR Medical SA; Director at Invectys, Inc.; and Venture Partner at SV Health Investors LLP since 2001.
Former jobs include Chairman-Ophthalmology Department & Professor at New York University School of Medicine; Director at NeoVista, Inc.; Director at Link Medicine Corp.; Director at Neurotech Pharmaceuticals, Inc. (United States); Non-Executive Director at Optos Plc in 2009; Independent Director at Beacon Therapeutics (USA), Inc. from 2014 to 2017; Independent Non-Executive Director at Oxurion NV from 2013 to 2023; Director at AlloCure, Inc.; Director at Carter BloodCare; Independent Director at EyePoint Plc from 2019 to 2024; Executive Vice President at OSI Pharmaceuticals, Inc.; and Venture Partner at SV Health Investors LLC.
Education includes a doctorate from The Johns Hopkins University School of Medicine and an undergraduate degree from Yale College.